Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWVV116 is an antiviral agent and a derivative of the antiviral prodrug remdesivir (Item No. 30354).1 It inhibits viral replication of respiratory syncytial virus (RSV) in A549 cells (EC50 = 1.01 µM). VV116 (25 mg/kg) decreases viral replication and lung viral titer counts in a mouse model of RSV infection. It also decreases alveolar inflammation in RSV-infected mice.
WARNING This product is not for human or veterinary use.
1. Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model. Signal Transduct. Target. Ther. 7(1), 123 (2022).